Objects
Jones, Michael Peter, Hruby, George, Martin, Jarad, Metser, Ur, Sridharan, Swetha, Capp, Anne, Kumar, Malesh, Gallagher, Sarah, Rutherford, Natalie, Holder, Carl, Oldmeadow, Christopher. BioMed Central; 2019. FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Jones, Michael, Hruby, George, Holder, Carl, Oldmeadow, Christopher, Martin, Jarad, Coolens, Catherine, Driscoll, Brandon, Stanwell, Peter, Kumar, Mahesh, Capp, Anne, Sridharan, Swetha, Arm, Jameen, Gallagher, Sarah. Elsevier Ireland; 2020. A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma.
Loh, Jasmin, Baker, Katie, Sridharan, Swetha, Greer, Peter, Wratten, Chris, Capp, Anne, Gallagher, Sarah, Martin, Jarad. BioMed Central; 2015. Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?.
Pryor, David, Sidhom, Mark, Martin, Jarad, Arumugam, Sankar, Bucci, Joseph, Gallagher, Sarah, Smart, Joanne, Grand, Melissa, Greer, Peter, Keats, Sarah, Wilton, Lee. Frontiers Research Foundation; 2019. Phase 2 multicenter study of gantry-based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (PROMETHEUS).
Richardson, Matthew, Sidhom, Mark, Pryor, David, Siva, Shankar, Martin, Jarad, Keall, Paul, Leigh, Lucy, Ball, Helen, Bucci, Joseph, Gallagher, Sarah, Greer, Peter, Hayden, Amy J., Kneebone, Andrew. Elsevier; 2023. Genitourinary Quality-of-Life Comparison Between Urethral Sparing Prostate Stereotactic Body Radiation Therapy Monotherapy and Virtual High-Dose-Rate Brachytherapy Boost.
Wegener, Eric, Sidhom, Mark, Arumugam, Sankar, Keats, Sarah, Brown, Simon, Glyde, Alan, Martin, Jarad M., Pryor, David, Bucci, Joseph, Yeoh, Kenway, Richardson, Matthew, Greer, Peter, Wilton, Lee, Gallagher, Sarah, Schmidt, Laurel. Elsevier; 2024. Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial.